Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2020 08:35 ET | Source: Aeterna Zentaris Inc

Aeterna Zentaris Reports Second Quarter 2020 Financial Results and Provides Business Update

– Positive results from AEZS-130-P01 (“Study P01”) confirmed dosing regimen of macimorelin as a potential diagnostic for childhood-onset growth hormone deficiency – Safety and efficacy...